Manfred Ahlgrimm

The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab

Manfred Ahlgrimm, Michael Pfreundschuh, Markus Kreuz et al. · Blood · 2011 · 66 citations · Full text

Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case–control study

Klaus‐Dieter Preuss, Manfred Ahlgrimm, Natalie Fadle et al. · The Lancet Oncology · 2009 · 63 citations

Hematological Malignancy, Monoclonal Gammopathy, Case–control Study +8

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab

Igor Age Kos, Benedikt Balensiefer, Sophie Roth et al. · Frontiers in Oncology · 2020 · 57 citations · Full text

A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS

Klaus‐Dieter Preuss, Michael Pfreundschuh, Manfred Ahlgrimm et al. · International Journal of Cancer · 2009 · 46 citations · Full text

Immunology, Pathology, Immunotherapy +20

Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: Inhibition of matrix metalloproteinases in pancreatic cancer

M. Kilian, J. I. Gregor, I. Heukamp et al. · Prostaglandins Leukotrienes and Essential Fatty Acids · 2006 · 42 citations

Tumor Biology, Pancreatic Cancer, Medicine +9